Boardroom Alpha
Boardroom Alpha
SFIX · Current Report (Form 8-K) · Filed April 1, 2026

Stitch Fix Inc — Current Report (Form 8-K)

Form
8-K
Filed
April 1, 2026
Period
Apr 1, 2026
Ticker
SFIX
Accession
0001628280-26-022847
Boardroom Alpha · Filing insights

Stitch Fix resumes share repurchases under its $150M program. Approximately $105M remains available.

Buyback authorized
About Stitch Fix Inc
Market cap
$481M
1Y TSR
−18.3%
3Y TSR
−4.9%
Board grade
C-
Sector
Consumer Cyclical
CEO
Matt Baer
Last annual meeting: Dec 11, 2025 · View full Stitch Fix Inc profile →
sfix-20260401

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 1, 2026
 
STITCH FIX, INC.
(Exact name of Registrant as Specified in Its Charter)
 
Commission file number: 001-38291
Delaware
27-5026540
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Montgomery Street, Suite 1500
San Francisco, California 94104
(Address of principal executive offices and zip code)
(415) 882-7765
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading SymbolName of Each Exchange on Which Registered
Class A common stock, par value $0.00002 per shareSFIXNasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 8.01Other Events.

On April 1, 2026, Stitch Fix, Inc. (the “Company”) announced that it has resumed repurchases under its existing share repurchase program. The share repurchase program was previously authorized by the Company’s Board of Directors in January 2022, and enables the Company to repurchase up to $150 million of its Class A common stock from time to time through open market repurchases, privately negotiated transactions, or other means, including pursuant to Rule 10b5-1 trading plans. The actual timing, number and value of shares repurchased in the future will be determined by the Company in its discretion and will depend on a number of factors, including price, trading volume, market conditions, and other general business conditions. The share repurchase program has no expiration date and may be modified, suspended, or terminated at any time. As of April 1, 2026, approximately $105 million remained available under the share repurchase program authorization.

A copy of the press release relating to these matters is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact could be deemed forward-looking, including but not limited to statements regarding the Company’s intentions with respect to its share repurchase program, including the timing, volume, and method of any future repurchases. These statements involve substantial risks and uncertainties, including risks and uncertainties related to the current macroeconomic environment; market conditions and the trading price and volume of the Company’s Class A common stock; the Company’s ability to complete repurchases under the share repurchase program in the amount authorized; the impact of the share repurchase program on the Company’s business and financial condition; and other risks described in the Company’s filings with the SEC. Further information on these and other factors that could cause the Company’s financial results, performance, and achievements to differ materially from any results, performance, or achievements anticipated, expressed, or implied by these forward-looking statements is included in filings the Company makes with the SEC from time to time, including in the section titled “Risk Factors” in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2026. These documents are available on the SEC Filings section of the investor relations section of the Company’s website at: https://investors.stitchfix.com. The Company undertakes no obligation to update any forward-looking statements made in this Current Report on Form 8-K to reflect events or circumstances after the date of this Current Report on Form 8-K or to reflect new information or the occurrence of unanticipated events, except as required by law. The achievement or success of the matters covered by such forward-looking statements involves known and unknown risks, uncertainties, and assumptions. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, the results of the Company could differ materially from the results expressed or implied by the forward-looking statements the Company makes. Investors should not rely upon forward-looking statements as predictions of future events. Forward-looking statements represent management's beliefs and assumptions only as of the date such statements are made.

Item 9.01Financial Statements and Exhibits.

(d)    Exhibits.

The following exhibits are provided as part of this Report:
Exhibit No.Description
99.1 
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  Stitch Fix, Inc.
   
Dated: April 1, 2026
 By:/s/ Casey O’Connor 
   Casey O’Connor
   Chief Legal Officer


From this filing to the watchlist

Catch material events the day they file.

Boardroom Alpha's monitors flag CEO/CFO transitions, restatements, going-concern risk, auditor changes, and 8-K events the day they hit EDGAR — across 6,000+ U.S. public companies. Daily digest by watchlist, API-accessible.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Stitch Fix Inc (SFIX)

Reference

Frequently asked questions

When did Stitch Fix Inc file this 8-K?
Stitch Fix Inc (SFIX) filed this Current Report (Form 8-K) with the SEC on April 1, 2026. The accession number assigned by EDGAR is 0001628280-26-022847.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stitch Fix resumes share repurchases under its $150M program. Approximately $105M remains available. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What events did Boardroom Alpha flag in this filing?
BA's event-extraction layer identified this signal in the filing text: "Buyback authorized". It appears above the filing body as a labeled pill.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Stitch Fix Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Stitch Fix Inc has filed under CIK 1576942, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer